Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

A Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants with or without Type 2 Diabetes

Participants needed: 180
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Alveus Therapeutics, Inc.Updated: Sep 28, 2026Locations: 3
Eligibility criteria

Adult male and female participants, aged 18 to 65 years, inclusive, at the time... [+7]

History or presence of any clinically relevant respiratory, metabolic (including... [+12]

Status: Recruiting

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

A study of ALV-100 to assess efficacy, safety and tolerability among participants with overweight or obesity who have previously achieved a body weight reduction of ≥10% while treated with incretin-based therapies.

Participants needed: 220
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Alveus Therapeutics, Inc.Updated: Sep 28, 2026Locations: 12
Eligibility criteria

Adult male and female participants, aged ≥18 to ≤75 [+5]

Lifetime history of Type 1 or Type 2 diabetes [+5]